Data-Driven Decision Making

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

A new partnership between Tealium and Diabolocom signals a major industry shift, turning contact centers into AI-powered, real-time revenue drivers.

A new partnership between Cowellnex and Metagen will use advanced DNA sequencing to create food recommendations tailored to each person's unique gut microbiome.

A new $3M endowed professorship at UMSOM, funded by state and private partners, aims to accelerate medical innovation by bridging engineering and medicine.

With a massive new investment led by NewSpring, physician-led Honest Health is set to expand its mission of transforming healthcare from volume to value.

A consulting firm's work optimizing ORs and sterile processing impacted over 1 million patients, revealing the crucial link between logistics and patient care.

Kolibri Global Energy Inc. just released its first sustainability report. Is it a genuine shift or a strategic play in a world demanding greener energy?

The ad-tech giant posted record revenue for 2025, but a weaker-than-expected forecast for early 2026 sent its stock tumbling. What's next?

IMO Health integrates a global rare disease database into EHRs, promising to shorten diagnosis times and accelerate vital research for millions.

The sports betting aggregator launches AtlasDFS, an integrated Pick'em game, aiming to become an all-in-one hub for fans amid fierce regulatory headwinds.

A new partnership adds 500M+ government-sourced locations to an open map project, aiming to revolutionize AI, analytics, and the geospatial industry.

Hawaiian beverage company Waiākea rolls out the world's first carbon-negative algae ink on its bottles, an open-source move to transform the industry.

P4ML joins the Orphan Therapeutics Accelerator to bring shelved cures to patients, leveraging a new non-profit model and expanding access to the MENA region.

Plus Therapeutics' REYOBIQ gains a crucial CPT code, a vital step in bringing this targeted radiotherapy to patients with aggressive brain cancers.

Medtech giant reveals its 'Magnificent Seven' innovations and new data, with Chief Movement Officer Arnold Schwarzenegger leading the charge at AAOS 2026.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

With the appointment of TechTarget co-founder Don Hawk, Life Science Connect is set to import a proven B2B intent data playbook into the life sciences.

New FDA-cleared Persona PLUS technology promises to increase plasma yields per donor, tackling the growing global demand for life-saving therapies.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

The $20B wealth firm appoints a veteran partner as its first CEO, signaling a new era of strategic growth while doubling down on its core values.